Paradigm Biopharmaceuticals | PAR - Sales Revenues

Stock Price
0.27
Daily Change
-0.01 -1.82%
Monthly
-15.63%
Yearly
-50.00%
Q1 Forecast
0.27

Paradigm Biopharmaceuticals reported AUD-8K in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Avita Medical AUD 18.42M 14K Jun/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
PYC Therapeutics AUD 13.48M 786.97K Jun/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025